A multi-cohort validated OXPHOS signature predicts survival and immune profiles in grade II/III glioma patients.
一项多队列验证的 OXPHOS 特征可预测 II/III 级胶质瘤患者的生存期和免疫特征
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1638824
Mou Jun, Zhang Min, Qin Fumin, Cui Yajie, Xu Keyou, Pang Baoye, Li Xinyue, Tan Wanyi, Yang Aiqi, Liu Yaxin, Shen Lingjun, Liu Yanting, Xu Kai